| Original language | English |
|---|---|
| Pages (from-to) | 2409-2411 |
| Number of pages | 3 |
| Journal | Journal of the American College of Cardiology |
| Volume | 72 |
| Issue number | 19 |
| DOIs | |
| Publication status | Published - 2018 Nov 6 |
Bibliographical note
Funding Information:Please note: † Drs. Jung and Sung contributed equally to this work. This study used the National Health Information Database from the National Health Insurance Service (NHIS) (NHIS-2018-4-018). This study was supported by a research grant from the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (NRF-2017R1A2B3003303) and grants from the Korean Healthcare Technology R&D project funded by the Ministry of Health & Welfare (HI16C0058, HI15C1200). Dr. Lip has served a consultant for Bayer/Janssen, Bristol-Myers Squibb/Pfizer, Medtronic, Boehringer Ingelheim, Novartis, Verseon, and Daiichi-Sankyo; and has served as a speaker for Bayer, Bristol-Myers Squibb/Pfizer, Medtronic, Boehringer Ingelheim, and Daiichi-Sankyo. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors would like to thank the NHIS for their cooperation.
All Science Journal Classification (ASJC) codes
- Cardiology and Cardiovascular Medicine